Balachandra Bandodkar
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Tuberculosis Research and Epidemiology, HIV/AIDS drug development and treatment, Malaria Research and Control
Most-Cited Works
- → Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis(2013)100 cited
- → Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents(2012)93 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure–activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-d-ribose 2′-oxidase(2015)58 cited
- → Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase(2013)48 cited
- → Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System(2014)47 cited
- → Repositioning: the fast track to new anti-malarial medicines?(2014)45 cited
- → Structure Guided Lead Generation for M. tuberculosis Thymidylate Kinase (Mtb TMK): Discovery of 3-Cyanopyridone and 1,6-Naphthyridin-2-one as Potent Inhibitors(2014)44 cited
- → Aminoazabenzimidazoles, a Novel Class of Orally Active Antimalarial Agents(2014)30 cited
- → Assessment of Mycobacterium tuberculosis Pantothenate Kinase Vulnerability through Target Knockdown and Mechanistically Diverse Inhibitors(2014)27 cited